MOTOKAZU SATO

Reduction of Tumor Biomarkers from very High to Normal and Extensive Metastatic Lesions to Undetectability in a Patient With Stage IV HER2-positive Breast Cancer Treated With Low-dose Trastuzumab Deruxtecan in Combination With Oral Recombinant Methioninase and a Low-methionine Diet

MOTOKAZU SATO, Qinghong Han, Ryosuke Mori et al. · Anticancer Research · 2024 · 27 citations · Full text

Medicine, Oncology, Pharmacology +17

Extensive Shrinkage and Long-term Stable Disease in a Teenage Female Patient With High-grade Glioma Treated With Temozolomide and Radiation in Combination With Oral Recombinant Methioninase and a Low-methionine Diet

MOTOKAZU SATO, Qinghong Han, KOHEI MIZUTA et al. · In Vivo · 2024 · 21 citations · Full text

Medicine, Nuclear Medicine, Radiation Oncology +13

Recombinant Methioninase Decreased the Effective Dose of Irinotecan by 15-fold Against Colon Cancer Cells: A Strategy for Effective Low-toxicity Treatment of Colon Cancer

MOTOKAZU SATO, Qinghong Han, Yutaro Kubota et al. · Anticancer Research · 2023 · 17 citations · Full text

Medicine, Oncology, Pharmacology +15

Selective Synergy of Rapamycin Combined With Methioninase on Cancer Cells Compared to Normal Cells

DANIEL ARDJMAND, Yutaro Kubota, MOTOKAZU SATO et al. · Anticancer Research · 2024 · 14 citations · Full text

Medicine, Oncology, Pharmacology +15

Extensive Synergy Between Recombinant Methioninase and Eribulin Against Fibrosarcoma Cells But Not Normal Fibroblasts

Sei Morinaga, Qinghong Han, Yutaro Kubota et al. · Anticancer Research · 2024 · 13 citations · Full text

Medicine, Cell Biology, Oncology +8